flunixin meglumine

CAS: 42461-84-7

Ref. IN-DA00I87V

Informação sobre produto

• Nome: flunixin meglumine
• Sinónimos: [u'Banamine', u'finadyne', u'Sch 14714 meglumine', u'42461-84-7', u'Flunixin meglumin', u'Banamine', u'finadyne', u'Flumeglumine', u'Flunixin-S', u'Sch 14714 meglumine', u'Flunixin N-methylglucanine', u'Banamine (Veterinary)', u'UNII-8Y3JK0JW3U', u'Sch-14714 meglumine', u'EINECS 255-836-0', u'8Y3JK0JW3U', u'CHEBI:76144', u'1-Deoxy-1-(methylamino)-D-glucitol 2-(2-methyl-3-(perfluoromethyl)anilino)nicotinate', u'2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid meglumine salt', u'2-(alpha(sup 3),alpha(sup 3),alpha(sup 3)-Trifluoro-2,3-xylidino)nicotinic acid compound with 1-deoxy-1-(methylamino)-D-glucitol (1:1)', u'1-Deoxy-1-(methylamino)-D-glucitol 2-[2-methyl-3-(perfluoromethyl)anilino]nicotinate', u'2-((2-Methyl-3-(trifluoromethyl)-phenyl)amino)-3-pyridinecarboxylic acid with meglumine compounded', u'3-Pyridinecarboxylic acid, 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)-, compd. with 1-deoxy-1-(methylamino)-D-glucitol (1:1)', u'D-Glucitol, 1-deoxy-1-(methylamino)-, 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)-3-pyridinecarboxylate (salt)', u'SMR000875279', u'SR-05000001901', u'Flunixin Meglumine [USAN]', u'Equileve', u'Ilium Flunixil', u'flunixin-meglumin', u'Flunixin meglumine [USAN:USP]', u'(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol;2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid', u'C14H11F3N2O2.C7H17NO5', u'PubChem15394', u'Flunixin meglumine (USP)', u'Flunixin N-Methylglucamine', u'Banamine [vetarynary] (TN)', u'SCHEMBL43691', u'BSPBio_002558', u'MLS001333159', u'MLS002153985', u'SPECTRUM1505113', u'AC1L21A7', u'CHEMBL1733447', u'CTK8F9789', u'C21H28F3N3O7', u'MGCCHNLNRBULBU-WZTVWXICSA-N', u'HMS2093I10', u'HMS2234K05', u'Pharmakon1600-01505113', u'HY-B0386', u'MFCD01725419', u'NIH 10250', u'NSC759583', u's2108', u'Flunixin meglumine, >=98% (HPLC)', u'AKOS015895954', u'AC-6012', u'API0025954', u'CCG-213338', u'CS-2460', u'KS-5126', u'NSC-759583', u'KS-000010G2', u'NCGC00180889-01', u'2-((2-methyl-3-(trifluoromethyl)- phenyl)amino)-3-pyridinecarboxylic acid with meglumine compounded', u'LS-71360', u'SC-18614', u'AB2000512', u'FT-0626443', u'SW196448-3', u'D04216', u'K-8817', u'AB00920714_05', u'AB00920714_06', u'461F847', u'C-22876', u'I06-1248', u'Q-201124', u'SR-05000001901-1', u'SR-05000001901-3', u'Flunixin meglumine, European Pharmacopoeia (EP) Reference Standard', u'Flunixin meglumine, United States Pharmacopeia (USP) Reference Standard', u'2-(2-Methyl-3-trifluoromethylanilino)nicotinic Acid N-Methyl-D-glucamine Salt', u'Flunixin Meglumine, Pharmaceutical Secondary Standard; Certified Reference Material', u'(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentaol 2-(2-methyl-3-(trifluoromethyl)phenylamino)nicotinate', u'(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol; 2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid', u'1-deoxy-1-(methylazaniumyl)-D-glucitol 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}nicotinate'], 1-Deoxy-1-(Methylamino)-D-Glucito-2-((2-Methyl-3-(Trifluoromethyl)Phenyl)Amino, 2-(2-Methyl-3-trifluoromethylanilino)nicotinic acid N-methyl-<span class="text-smallcaps">D</span>-glucamine salt, 2-{[2-Methyl-3-(trifluoromethyl)phenyl]amino}nicotinic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1), 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1), 3-Pyridinecarboxylic acid, 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-, compd. with 1-deoxy-1-(methylamino)-<span class="text-smallcaps">D</span>-glucitol (1:1), 3-pyridinecarboxylic acid, 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-, compd. with D-glucitol, 1-deoxy-1-(methylamino)- (1:1), <span class="text-smallcaps">D</span>-Glucitol, 1-deoxy-1-(methylamino)-, 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylate (1:1), <span class="text-smallcaps">D</span>-Glucitol, 1-deoxy-1-(methylamino)-, 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylate (salt), Banamine, Equileve, Finadyne, Finadyne RP, Flunimeg, Flunixin N-methylglucamine, Flunixin meglumin, Ilium flunixil, Nih 10250, D-Glucitol, 1-deoxy-1-(methylamino)-, 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylate (1:1), 3-Pyridinecarboxylic acid, 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-, compd. with 1-deoxy-1-(methylamino)-D-glucitol (1:1), 2-(2-Methyl-3-trifluoromethylanilino)nicotinic acid N-methyl-D-glucamine salt, D-Glucitol, 1-deoxy-1-(methylamino)-, 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylate (salt)
• Marca: Indagoo

Propriedades químicas

• Peso molecular: 491.4581
• Fórmula: C₂₁H₂₈F₃N₃O₇
• Pureza: 98%
• Cor/forma: Solid
• InChI: InChI=1S/C14H11F3N2O2.C7H17NO5/c1-8-10(14(15,16)17)5-2-6-11(8)19-12-9(13(20)21)4-3-7-18-12;1-8-2-4(10)6(12)7(13)5(11)3-9/h2-7H,1H3,(H,18,19)(H,20,21);4-13H,2-3H2,1H3/t;4-,5+,6+,7+/m.0/s1
• Chave InChI: MGCCHNLNRBULBU-WZTVWXICSA-N